Juno and AstraZeneca pair two hot immunotherapies in new cancer study
Juno Therapeutics ($JUNO) and AstraZeneca ($AZN) are joining…
Virtual biotechs a hit with investors and, increasingly, buyers
Biotech venture capitalists have increasingly embraced the virtual…
Big Pharma-backed Dutch immuno-oncology player eyes €100M Nasdaq IPO
A Dutch immuno-oncology player that has received venture funding…
Personal cancer vaccine research ‘exciting’ say experts
Tailor-made cancer vaccines that target unique genetic errors…